Pharmacotherapy of premenstrual syndromes and premenstrual disphoric disorder: current practices

Author： Mitwally Mohamed F   Kahn Linda S   Halbreich Uriel  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.11, 2002-11, pp. : 1577-1590

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Premenstrual dysphoric disorder: is it simply PMS?

By Endicott J.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 259-259

Elsevier

Access to resources Recommend Favorite

Duloxetine for premenstrual dysphoric disorder: a pilot study

By Mazza Marianna   Harnic Desiree   Catalano Valeria   Janiri Luigi   Bria Pietro  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 517-521

Informa Healthcare

Access to resources Recommend Favorite

Are there Differential Symptom Profiles that Improve in Response to Different Pharmacological Treatments of Premenstrual Syndrome/Premenstrual Dysphoric Disorder?

By Halbreich Uriel  

CNS Drugs, Vol. 20, Iss. 7, 2006-01 ,pp. : 523-547

Adis International

Access to resources Recommend Favorite

Fluctuating serotonergic function in premenstrual dysphoric disorder and premenstrual syndrome: findings from neuroendocrine challenge tests

By Inoue Y.   Terao T.   Iwata N.   Okamoto K.   Kojima H.   Okamoto T.   Yoshimura R.   Nakamura J.  

Psychopharmacology, Vol. 190, Iss. 2, 2007-02 ,pp. : 213-219

Springer Publishing Company

Access to resources Recommend Favorite

Therapeutic patents for the treatment of premenstrual syndrome and premenstrual dysphoric disorder: historical perspectives and future directions

By Ross Lori E   Steiner Meir  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 10, 2003-10 ,pp. : 1491-1499

Informa Healthcare

Access to resources Recommend Favorite